MENU
KYTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kyverna Therapeutics (KYTX) Ownership - Who owns Kyverna Therapeutics?

Profile

Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
96
Web
https://www.kyvernatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
132.54M
P/E Ratio
N/A
Total Cash
321.59M
Projected Growth
N/A
Total Debt
9.14M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

KYTX
Capitalization
133M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
322M
Total Cash/Share
7.45
Total Debt
9.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
303M
P/B Ratio
0.44
Cash Flow
N/A
Earnings
-2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
10.50
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-108.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-51.27
Shares Held By Institutions
203M
Shares Outstanding - Current
43.2M
Total Liabilities
36.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-17.112
View a ticker or compare two or three
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
96
Web
https://www.kyvernatx.com